Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
08/2005
08/04/2005WO2005070946A1 Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound
08/04/2005WO2005070859A1 Fluorous supports and processes for production of oligonucleotide derivatives with the same
08/04/2005WO2005063787A3 Propargyl substituted nucleoside compounds and methods
08/04/2005WO2005020885A3 Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
08/04/2005US20050171342 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
08/04/2005US20050171126 Process for the production of purine nucleoside compounds
08/04/2005US20050171060 Anticancer agents and drug delivery agents with nucleotides
08/04/2005US20050171051 Pharmaceutical composition for diabetic neuropathy
08/04/2005US20050171049 Compounds for the treatment of ischemia
08/04/2005US20050171048 Nuclease activity resistance; mixed sequence oligonucleotides containing purine or pyrimidine base in beta anomeric configuration; drug delivery agents; targeting specific DNA and/or RNA sequences
08/04/2005US20050170423 Systems and methods for transgenic and targeted mutagenesis screening
08/04/2005US20050170388 Pyrimidine nucleobases
08/04/2005US20050170367 For polymerase screening
08/04/2005US20050170340 Solid support comprising a plurality of immobilized, positionally distinguishable, multi-subunit sequence specific reagents for use in characterization and classification of biological samples; immunoaffinity chromatography
08/04/2005CA2554618A1 Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound
08/04/2005CA2552552A1 Synthesis of spongosine
08/03/2005EP1558757A1 Gas jet process and apparatus for high-speed amplification of dna
08/03/2005EP1558748A2 Cell lysis compositions, methods of use, apparatus, and kit
08/03/2005CN1649935A Monomers containing polyoxyalkylenes and polymer supports therefrom
08/03/2005CN1649889A Process for preparing oligonucleotides
08/03/2005CN1649888A 4'-Deoxy-4'-(s)-amido avermectin derivatives
08/02/2005US6924272 Medicinal composition for diabetic neuropathy
08/02/2005US6924271 Having immunomodulatory activity, for therapy and prophylaxis of diseases
08/02/2005US6924270 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
08/02/2005CA2105112C A process for anomerizing nucleosides
07/2005
07/28/2005WO2005067960A1 HIV gp41 HR2-DERIVED SYNTHETIC PEPTIDES, AND THEIR USE IN THERAPY TO INHIBIT TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS
07/28/2005WO2005067644A2 Conjugated small molecules
07/28/2005WO2005035545A3 Single nucleotide polymorphism analysis of highly polymorphic target sequences
07/28/2005WO2005033121A3 Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
07/28/2005US20050164974 Ligand is covalently linked to polyoxyethylene glycol having specific binding affinity for vascular endothelial growth factor; SELEX method; improved pharmacokinetics
07/28/2005US20050164960 Administering substituted (beta -D-ribofuranosyl)purines or (beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidines alone or incombination with cidofovir, ribavirin, levovirin, or viramidine, particularly against vaccinia virus or variola virus infections
07/28/2005US20050164268 Oncology diagnosis; gene overexpression/underexpression; tumor suppressor genes
07/28/2005US20050164249 Solid support comprising a plurality of immobilized, positionally distinguishable, multi-subunit sequence specific reagents for use in characterization and classification of biological samples; immunoaffinity chromatography
07/28/2005US20050164182 Nucleoside comprising reporter molecule cleavable by hydrolase such as esterases, phosphatases, peptidases, penicillin amidases, glycosidases, and phosphorylases; limits polymerase activity; sequencing; solid phase synthesis
07/28/2005DE102004034228A1 Verfahren zur Herstellung einer Pyrimidinnucleosidverbindung und einer neuen Pyrimidinnucleosidverbindung A process for preparing a pyrimidine nucleoside compound and a new pyrimidine nucleoside compound
07/28/2005CA2551495A1 Conjugated small molecules
07/28/2005CA2551082A1 Hiv gp41 hr2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
07/27/2005EP1557424A1 Bi-cyclic nucleoside, nucleotide and oligonucleoide analogues
07/27/2005EP1556400A2 Method for the preparation of 2-halo-2 -deoxyadenosine compounds from 2 -deoxyguanosine
07/27/2005EP1556399A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
07/27/2005EP1556398A1 Novel cytarabine monophosphate prodrugs
07/27/2005EP1556393A2 Novel cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
07/27/2005CN1646544A Process for manufacturing purified phosphorodiamidite
07/27/2005CN1646534A Modified fluorinated nucleoside analogues
07/27/2005CN1646452A Methods of producing phosphitylated compounds
07/27/2005CN1646142A Method of treating arrhythmias comprising administration of an A1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside
07/27/2005CN1646141A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
07/27/2005CN1646129A Dosing regimen for gemcitabine HCV therapy
07/27/2005CN1645148A Reagent box for inspecting infection of swine pleuropneumonia actinomyces
07/27/2005CN1644585A Covalently linked oligonucleotide minor grove binder conjugates
07/26/2005US6921818 Using silyl compositions that can be directly coupled, or coupled through linking group, to compound of interest, preferably to oligomer at end of oligomer synthesis; silicon atom includes 1-3 sidechains that function as capture tags
07/26/2005US6921812 Increasing the binding of oligomeric compounds to proteins, e.g.,human serum albumin, and oligomeric high binding affinity to target RNA by using 2'-O-(2-Methylthioethyl) modified oligonucleotides; antisense drugs; enzyme resistance
07/26/2005US6921753 As agonists of the human adenosine A2a receptor and may be used as anti-inflammatory agents in therapy of inter alia, diseases of respiratory tract
07/21/2005US20050159392 Phosphoramidate linkages; retroviral or hepadnaviral therapy; tissue targeted therapy; HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability
07/21/2005US20050158772 Nucleic acid analysis techniques
07/21/2005US20050158743 Arrays for detecting nucleic acids
07/20/2005EP1554398A2 Apparatus and method for preparative scale purification of nucleic acids
07/20/2005EP1554300A1 Phosphitylation process
07/20/2005EP1554298A1 Process for the preparation of 9-beta-anomeric nucleoside analogs
07/20/2005CN1642923A Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones
07/20/2005CN1640883A Method for synthesizing 2', 3'-dideoxy cytidine
07/20/2005CN1640882A Method for synthesizing 5-trifluoro methyl-2'-desugarized uridine
07/20/2005CN1211089C Application of uridine phosphorylase inhibitor and composition containing the same
07/19/2005US6919445 Detecting with a multicolor fluorescent dyes, for automated 4-DNA sequencing systems, identifying the classes of the polynucleotides
07/19/2005US6919439 Derivatized oligonucleotides having improved uptake and other properties
07/19/2005US6919320 Pharmaceutical compositions containing deoxyribonucleosides for wound healing
07/19/2005US6919211 Solid support comprising amino acid sequences for sequencing, fingerprinting and mapping biological macromolecules; structure and function analysis
07/19/2005US6919179 Generating labeled proteins; obtain nucleotide sequences, incubate with cell free translation system, recover labeled protein
07/14/2005WO2005063788A1 Benzimidazole derivatives and medical uses thereof
07/14/2005WO2005063787A2 Propargyl substituted nucleoside compounds and methods
07/14/2005WO2005063786A2 Process for fluorocytidine derivatives
07/14/2005WO2005021778A3 Method and materials for polyamine catalyzed bisulfite conversion of cytosine to uracil
07/14/2005US20050153371 Conjugated small molecules
07/14/2005US20050153363 Polymer arrays
07/14/2005US20050153362 Polymer arrays
07/14/2005US20050153355 Water-soluble rhodamine dye conjugates
07/14/2005US20050153308 Method and materials for polyamine catalyzed bisulfite conversion of cytosine to uracil
07/13/2005EP1553102A1 Synthesis of oligonucleotides
07/13/2005EP1552013A1 Microfluidic device including purification column with excess diluent, and method
07/13/2005EP1552007A1 Multiplex genotyping using solid phase capturable dideoxynucleotides and mass spectrometry
07/13/2005EP1551421A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
07/13/2005CN1639182A Processes for the synthesis of 5'-deoxy-5' chloroadenosine and 5'-deoxy-5'methylthioadenosine
07/12/2005US6916937 For ishcemia/stroke therapy; calcium-activated potassium channel modulators
07/12/2005US6916794 Method of enhancing drainage of lacrimal system with purinergic receptor agonists
07/12/2005US6916616 Stabilized aqueous nucleoside triphosphate solutions
07/12/2005US6916612 Sets of oligonucleotide-binding e-tag probes
07/12/2005CA2146047C 13-substituted milbemycin derivatives, their preparation and use
07/07/2005WO2004082822A3 Methods for isolating crystalline form i of 5-azacytidine
07/07/2005WO2003063771A3 N4-acylcytosine nucleosides for treatment of viral iinfections
07/07/2005WO2003053360A3 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
07/07/2005US20050148539 Fused pentacyclic polyethers
07/07/2005US20050148073 Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors
07/07/2005US20050148027 Very large scale immobilized polymer synthesis
07/07/2005US20050148002 Sequence of surface immobilized polymers utilizing microfluorescence detection
07/07/2005US20050147984 Interaction detection on several probe arrays
07/06/2005EP1550665A1 A process for the production of purine nucleoside compounds
07/06/2005EP1549755A2 Spliceosome mediated rna trans-splicing in stem cells
07/06/2005EP1060264B1 Dideoxy dye terminators
07/06/2005CN1636009A Partial and full agonists of a1 adenosine receptors
07/06/2005CN1635901A Remodeling and glycoconjugation of peptides
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 201